Synergistic effect of quinacrine in combination with decitabine for the treatment of acute myeloid leukemia cells in vitro: implication for treatment of AML in the elderly

被引：0
|
作者：
Wang, Wenge [1 ]
Dicker, David T. [2 ,3 ]
Claxton, David F. [1 ]
Wang, Hong-Gang [4 ]
El-Deiry, Wafik S. [2 ,3 ]
机构：
[1] Penn State Hershey Med Ctr, Inst Canc, Hematol Oncol, Hershey, PA USA
[2] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[3] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
[4] Penn State Coll Medicne, Dept Pediat, Hershey, PA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3486
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3486
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
    A Eriksson
    A Österroos
    S Hassan
    J Gullbo
    L Rickardson
    M Jarvius
    P Nygren
    M Fryknäs
    M Höglund
    R Larsson
    Blood Cancer Journal, 2015, 5 : e307 - e307
  • [22] ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms
    Mannelli, Francesco
    Guglielmelli, Paola
    Fazi, Paola
    Crea, Enrico
    Piciocchi, Alfonso
    Vignetti, Marco
    Amadori, Sergio
    Pane, Fabrizio
    Venditti, Adriano
    Vannucchi, Alessandro M.
    FUTURE ONCOLOGY, 2023, 19 (02) : 103 - 111
  • [23] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    BLOOD, 2019, 133 (01) : 7 - 17
  • [24] Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia
    Tan, Kuan-Boone
    Ling, Leong-Uung
    Bunte, Ralph M.
    Chng, Wee-Joo
    Chiu, Gigi N. C.
    NANOMEDICINE, 2014, 9 (11) : 1665 - 1679
  • [25] Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
    Eriksson, A.
    Osterroos, A.
    Hassan, S.
    Gullbo, J.
    Rickardson, L.
    Jarvius, M.
    Nygren, P.
    Fryknas, M.
    Hoglund, M.
    Larsson, R.
    BLOOD CANCER JOURNAL, 2015, 5 : e307 - e307
  • [26] MITOXANTRONE AND ETOPOSIDE (M/E) COMBINATION IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML)
    BERNASCONI, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 279 - 280
  • [27] ACLACINOMYCIN IN TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML)
    MACHOVER, D
    GASTIABURU, J
    DELGADO, M
    GOLDSCHMIDT, E
    HULHOVEN, R
    MISSET, JL
    DEVASSAL, F
    TAPIERO, H
    RIBAUD, P
    SCHWARZENBERG, L
    MATHE, G
    ANTICANCER RESEARCH, 1985, 5 (06) : 634 - 634
  • [28] REPOSITIONING OF QUINACRINE FOR TREATMENT OF ACUTE MYELOID LEUKEMIA - SYNERGIES AND IN VIVO EFFECTS
    Eriksson, A.
    Gustafsson, M.
    Fryknas, M.
    Gullbo, J.
    Nygren, P.
    Hoglund, M.
    Larsson, R.
    HAEMATOLOGICA, 2016, 101 : 367 - 368
  • [29] Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience.
    Ganetsky, A.
    Adel, N. G.
    Frattini, M. G.
    Maslak, P. G.
    Heaney, M. L.
    Jurcic, J. G.
    Tallman, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Treatment of acute myeloid leukemia in the elderly patient
    Kuse, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (09) : 272 - 272
12345